Skip to main content
Bradley Prestidge, MD, Radiation Oncology, Spring, TX, Baptist Health Floyd

BradleyRobertPrestidgeMDMS, FABS

Radiation Oncology Spring, TX

Urologic Cancer

Radiation Oncologist, Houston, TX

Dr. Prestidge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Prestidge's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 1986 - 1989
  • David Grant Medical Center
    David Grant Medical CenterInternship, Internal Medicine, 1985 - 1986
  • UniforMed Services University of the Health Sciences F. Edward Hebert School of Medicine
    UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - Present
  • IL State Medical License
    IL State Medical License 2024 - 2026
  • KY State Medical License
    KY State Medical License 2023 - 2025
  • CO State Medical License
    CO State Medical License 2021 - 2025
  • TX State Medical License
    TX State Medical License 1990 - 2025
  • AL State Medical License
    AL State Medical License 2023 - 2024
  • NM State Medical License
    NM State Medical License 2021 - 2024
  • American Board of Radiology Radiation Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Fellow American Brachytherapy Society, 2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Dr. Bradley Prestidge | 2019 Health Care Hero for Radiation Oncology
    Dr. Bradley Prestidge | 2019 Health Care Hero for Radiation OncologyMarch 1st, 2019
  • No Benefit Observed from Combined Irradiation in Intermediate-Risk Prostate Cancer
    No Benefit Observed from Combined Irradiation in Intermediate-Risk Prostate CancerOctober 6th, 2016
  • ASTRO: Brachytherapy Enough for Mid-Risk Prostate Cancer
    ASTRO: Brachytherapy Enough for Mid-Risk Prostate CancerSeptember 30th, 2016

Professional Memberships

Hospital Affiliations